U.S. Health Secretary Robert F. Kennedy Jr. announced a halt to nearly $500 million in federal funding for mRNA vaccine projects. The decision has been met with mixed reactions — some see it as a responsible reallocation of resources, while others fear it will undermine future pandemic preparedness. The mRNA technology, made famous during the COVID-19 pandemic, has shown potential in fighting other diseases, including certain cancers. Health experts worry that cutting funding now could slow medical innovation. Meanwhile, political opponents accuse the administration of making the move based on ideology rather than science.
- charging reliability improving but satisfaction drops amid cost and complexity
- cancelled ev programs show automaker retreat
- tariffs cause polestar to report billion-dollar loss in q2
- dodge charger ev recall for being too quiet and unsafe
- polestar 3 recalled over water-damage risk in electrical system
- gm’s new adapters highlight ev charging standards confusion
- tesla model y auto window recall in australia over crush risk
- bmw recalls over 70k evs for possible power loss while driving
- uk warns charging must become as easy as filling up at the pump
- us states suing federal govt over ev infrastructure rollback
- limited battery recycling options raise environmental concerns
- electric car tire wear faster than expected
- charging station reliability problems drivers complain about
- battery replacement cost electric cars real numbers
- lack of charging stations in rural areas still a big problem